|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/14/18 Emmaus Life Sciences, Inc. 10-Q 3/31/18 65:4.9M S2 Filings LLC/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 436K
2: EX-3.2 Articles of Incorporation/Organization or Bylaws HTML 48K
3: EX-10.3 Material Contract HTML 55K
4: EX-10.4 Material Contract HTML 28K
5: EX-10.5 Material Contract HTML 22K
6: EX-10.6 Material Contract HTML 21K
7: EX-10.7 Material Contract HTML 22K
8: EX-31.1 Certification -- §302 - SOA'02 HTML 23K
9: EX-31.2 Certification -- §302 - SOA'02 HTML 23K
10: EX-32.1 Certification -- §906 - SOA'02 HTML 19K
17: R1 Document and Entity Information HTML 45K
18: R2 Unaudited Condensed Consolidated Balance Sheets HTML 112K
19: R3 Unaudited Condensed Consolidated Balance Sheets HTML 43K
(Parenthetical)
20: R4 Unaudited Condensed Consolidated Statements of HTML 62K
Operations
21: R5 Unaudited Condensed Consolidated Statements of HTML 95K
Cash Flows
22: R6 Organization, Nature of Operations and Going HTML 34K
Concern Uncertainty
23: R7 Summary of Significant Accounting Policies HTML 83K
24: R8 Accounts Receivable HTML 25K
25: R9 Long - Term Borrowings and Other Note Payables HTML 25K
26: R10 Acquisition HTML 55K
27: R11 Stockholders' Equity HTML 150K
28: R12 Convertible Preferred Stock HTML 36K
29: R13 Income Taxes HTML 27K
30: R14 Related Party Transactions HTML 24K
31: R15 Loss Per Share HTML 39K
32: R16 Commitments and Contingent Liabilities HTML 33K
33: R17 Subsequent Events HTML 30K
34: R18 Summary of Significant Accounting Policies HTML 144K
(Policies)
35: R19 Summary of Significant Accounting Policies HTML 30K
(Tables)
36: R20 Accounts Receivable (Tables) HTML 25K
37: R21 Acquisition (Tables) HTML 49K
38: R22 Stockholders' Equity (Tables) HTML 101K
39: R23 Loss Per Share (Tables) HTML 37K
40: R24 Organization, Nature of Operations and Going HTML 38K
Concern Uncertainty (Details Narrative)
41: R25 Summary of Significant Accounting Policies HTML 24K
(Details)
42: R26 Summary of Significant Accounting Policies HTML 32K
(Details 1)
43: R27 Summary of Significant Accounting Policies HTML 70K
(Details Narrative)
44: R28 Accounts Receivable (Details) HTML 26K
45: R29 Long - Term Borrowings and Other Note Payables HTML 45K
(Details Narrative)
46: R30 Acquisition (Details) HTML 65K
47: R31 Acquisition (Details 1) HTML 27K
48: R32 Acquisition (Details Narrative) HTML 52K
49: R33 Stockholders' Equity (Details) HTML 30K
50: R34 Stockholders' Equity (Details 1) HTML 25K
51: R35 Stockholders' Equity (Details 2) HTML 52K
52: R36 Stockholders' Equity (Details 3) HTML 38K
53: R37 Stockholders' Equity (Details 4) HTML 31K
54: R38 Stockholders' Equity (Details 5) HTML 54K
55: R39 Stockholders' Equity (Details Narrative) HTML 401K
56: R40 Stockholders' Equity (Details Narrative 1) HTML 69K
57: R41 Convertible Preferred Stock (Details Narrative) HTML 56K
58: R42 Income Taxes (Details Narrative) HTML 36K
59: R43 Related Party Transactions (Details Narrative) HTML 33K
60: R44 Loss Per Share (Details) HTML 40K
61: R45 Commitments and Contingent Liabilities (Details HTML 71K
Narrative)
62: R46 Subsequent Events (Details Narrative) HTML 58K
64: XML IDEA XML File -- Filing Summary XML 105K
63: EXCEL IDEA Workbook of Financial Reports XLSX 86K
11: EX-101.INS XBRL Instance -- mynd-20180331 XML 1.36M
13: EX-101.CAL XBRL Calculations -- mynd-20180331_cal XML 153K
14: EX-101.DEF XBRL Definitions -- mynd-20180331_def XML 643K
15: EX-101.LAB XBRL Labels -- mynd-20180331_lab XML 960K
16: EX-101.PRE XBRL Presentations -- mynd-20180331_pre XML 808K
12: EX-101.SCH XBRL Schema -- mynd-20180331 XSD 140K
65: ZIP XBRL Zipped Folder -- 0001615774-18-003746-xbrl Zip 147K
Exhibit 10.6
SECOND AMENDMENT TO CHAIRMAN SERVICES AGREEMENT
This Second Amendment to Chairman Services Agreement (“Amendment”) is made by and between MYnd Analytics, Inc. (hereinafter “MYnd”) and Robin Smith MD MBA (hereinafter “Advisor”) is effective as of April 24, 2018 (the “Effective Date”).
On or about July 14, 2017, Advisor and Mynd entered into the above Chairman Services Agreement for services.
The parties agree that the Agreement will be amended as follows: Advisor’s annual cash fee for the 2018 calendar year will be reduced from $300,000 to $250,000. This change is retroactive to January 1, 2018. Further, the grant of options on April 16, 2018 by the Board of Directors to purchase 150,000 shares of common stock under the Company’s Amended and Restated 2012 Omnibus Incentive Compensation Plan (the”2012 Plan”), shall be reduced to 50,000 shares, without any other change to the terms thereof.
Except as expressly modified by this Amendment, the_ Agreement shall be and remain in full force and effect in accordance with its terms and shall constitute the legal, valid, binding and enforceable obligations to the parties. This Second Amendment and the Agreement (including any written amendments thereto), collectively, are the complete agreement of the parties and supersede any prior agreements or representations, whether oral or written, with respect thereto.
Agreed and Accepted:
| Date: Apr 24, 2018 | Date: | |||
| Advisor | Mynd Analytics, Inc. | |||
| By: | /s/ Robin Smith | By: | /s/ Don D’Ambrosio | |
| Robin Smith MD MBA | Don D’Ambroso, CFO | |||
C:
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/14/18 | |||
| 4/24/18 | 4/A, 8-K/A | |||
| 4/16/18 | 8-K | |||
| For Period end: | 3/31/18 | |||
| 1/1/18 | ||||
| 7/14/17 | 4, 8-K, EFFECT | |||
| List all Filings | ||||